Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s What Happened

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s share price gapped down prior to trading on Monday . The stock had previously closed at $8.74, but opened at $8.08. Curaleaf shares last traded at $8.72, with a volume of 3,814 shares traded.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Three research analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. Based on data from MarketBeat.com, Curaleaf has an average rating of “Strong Buy”.

Curaleaf Price Performance

The company has a current ratio of 1.56, a quick ratio of 0.74 and a debt-to-equity ratio of 1.05. The stock has a 50-day simple moving average of $7.07 and a 200 day simple moving average of $7.68. The stock has a market capitalization of $2.10 billion, a price-to-earnings ratio of -23.10 and a beta of 1.56.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.51. The business had revenue of $324.23 million during the quarter, compared to analyst estimates of $316.62 million. Curaleaf had a negative net margin of 7.76% and a negative return on equity of 8.11%. On average, equities research analysts forecast that Curaleaf Holdings, Inc. will post -0.31 EPS for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.